Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab-Reference-Cited by-同舟云学术

Peripheral Blood Biomarkers Associated with Clinical Outcome in Non–Small Cell Lung Cancer Patients Treated with Nivolumab

Published:2018-01 Issue:1 Volume:13 Page:97-105
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Tanizaki Junko,Haratani Koji,Hayashi Hidetoshi,Chiba Yasutaka,Nakamura Yasushi,Yonesaka Kimio,Kudo Keita,Kaneda Hiroyasu,Hasegawa Yoshikazu,Tanaka Kaoru,Takeda Masayuki,Ito Akihiko,Nakagawa Kazuhiko

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

2. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

3. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N Engl J Med,2015

4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N Engl J Med,2015

5. Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab;Ferrucci;Ann Oncol,2016

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SLC4A4 as a novel biomarker involved in immune system response and lung adenocarcinoma progression;International Immunopharmacology;2024-10

2. Prognostic value of a novel myeloid-to-lymphoid ratio biomarker in advanced gastric cancer;Clinical and Translational Oncology;2024-08-14

3. Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain Metastasis;Current Oncology;2024-08-09

4. Predictive Value of Lymphocyte‐to‐Neutrophil Ratio and Platelet‐to‐Neutrophil Ratio on PD‐L1 Expression in Lung Cancer;The Clinical Respiratory Journal;2024-08

5. Epidermal growth factor receptor and programmed cell death‐1 expression levels in peripheral T cell subsets of patients with non‐small cell lung cancer;Scandinavian Journal of Immunology;2024-07-29